“Unanswered questions”: Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study

BACKGROUND: Based on the relevant differences in breast cancer risk, strategies for personalizing population screening have been proposed. The present study was conducted in the context of the MyPEBS study, which seeks to improve the evidence on the benefits and risks of implementing personalized screening. We explored the views of healthcare professionals involved in the MyPeBS study on the acceptability to extend the screening interval in women at lower risk, as proposed by MyPeBS. METHODS: Qualitative interpretative descriptive study. Twelve health professionals were interviewed individually and in a discussion group. The transcripts were analysed using thematic analysis. RESULTS: For healthcare professionals, the low risk estimate was good news for women. However, the acceptability of decreasing screening frequency was not homogeneous. A lower uptake seemed to be mainly influenced by previous participation in current population-based screening. Several uncertainties were raised for acceptability: the benefits of such personalization for lower-risk women, how to guarantee equity, and the feasibility of this de-escalation in terms of human and financial resources. CONCLUSION: Previous participation in screening was the most significant factor for women's low acceptance of decreasing screening frequency. Future research should refine the views of health professionals and women. Recommendations should be made to promote participation in personalized screening of women at lower risk.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-04-30
DOI
https://doi.org/10.1371/journal.pone.0347029
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“Unanswered questions”: Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study

Sandrine de Montgolfier, M Pera Román, Xavier Castells, Celmira Laza-Vásquez et al.
PLoS ONE
BRCA gene mutations in cancer
article

“Unanswered questions”: Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study

Sandrine de Montgolfier, M Pera Román, Xavier Castells, Celmira Laza-Vásquez, Suzette Delaloge
article en

Abstract

BACKGROUND: Based on the relevant differences in breast cancer risk, strategies for personalizing population screening have been proposed. The present study was conducted in the context of the MyPEBS study, which seeks to improve the evidence on the benefits and risks of implementing personalized screening. We explored the views of healthcare professionals involved in the MyPeBS study on the acceptability to extend the screening interval in women at lower risk, as proposed by MyPeBS. METHODS: Qualitative interpretative descriptive study. Twelve health professionals were interviewed individually and in a discussion group. The transcripts were analysed using thematic analysis. RESULTS: For healthcare professionals, the low risk estimate was good news for women. However, the acceptability of decreasing screening frequency was not homogeneous. A lower uptake seemed to be mainly influenced by previous participation in current population-based screening. Several uncertainties were raised for acceptability: the benefits of such personalization for lower-risk women, how to guarantee equity, and the feasibility of this de-escalation in terms of human and financial resources. CONCLUSION: Previous participation in screening was the most significant factor for women's low acceptance of decreasing screening frequency. Future research should refine the views of health professionals and women. Recommendations should be made to promote participation in personalized screening of women at lower risk.

PLoS ONEVol. 21(4)
Inserm (FR), Universitat de Lleida (ES), Institut Gustave Roussy (FR), Hospital Del Mar (ES), Economic & Social Sciences, Health Systems & Medical Informatics (FR), Institut de Recherche pour le Développement (FR)
Instituto de Salud Carlos III, H2020 European Research Council
Gender equality
Openalex Percentile: Top 12%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.